Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia (Q93529759)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

title

Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

main subject

phase II clinical trial

1 reference

1 reference

E Archimbaud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

J Troncy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

C Sebban

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

D Guyotat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

Y Devaux

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

M French

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

M Moriceau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

J J Viala

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

D Fiere

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

7 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

page(s)

223-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

Therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.

7 May 2020

cites work

1 reference

12 December 2020

Erythroid differentiation in cultured Friend leukemia cells treated with metabolic inhibitors

1 reference

12 December 2020

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

12 December 2020

Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.

1 reference

12 December 2020

Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults

1 reference

12 December 2020

Inhibition of ribonucleoside diphosphate reductase by hydroxyurea

1 reference

12 December 2020

Low dose cytosine arabinoside in myelodysplasia and acute myelogenous leukemia: a review

1 reference

12 December 2020

Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by compounds which induce differentiation of murine leukemia cells

1 reference

12 December 2020

Mithramycin inhibition of ribonucleic acid synthesis

1 reference

12 December 2020

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

12 December 2020

Chronic myelogenous leukemia--new concepts (first of two parts).

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00689589

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2532073%20AND%20SRC:MED&resulttype=core&format=json

7 May 2020

1 reference